CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $2.54B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.3: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.15%Below 5Y avg (2.66%)
Annual Rate
CNY 0.18Paid annual
Payout Ratio
109.5%High
Payback Period
86.2 yr
Last Ex-Dividend
Aug 6, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
17.07BCNY2.54B · vs all stocks (USD)
Trailing P/E
44.97xRevenue (TTM)
11.67BCNY1.74B · vs all stocks (USD)
Profit Margin
3.20%Beta
0.2960xvs all stocks
52-Week Change
-17.71%vs all stocks
Market Capitalization
17.07BCNY2.54B · vs all stocks (USD)
Enterprise Value
18.49BCNY2.75B · vs all stocks (USD)
Trailing P/E
44.97xPrice to Sales (TTM)
1.46xPrice to Book (MRQ)
1.67xEnterprise to Revenue
1.58xEnterprise to EBITDA
11.53xGross Margin
63.35%Profit Margin
3.20%Operating Margin
16.79%Return on Assets (TTM)
3.80%Return on Equity (TTM)
2.09%Revenue (TTM)
11.67BCNY1.74B · vs all stocks (USD)
Revenue per Share (TTM)
11.07CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-7.40%Gross Profit (TTM)
7.11BCNY1.06B · vs all stocks (USD)
EBITDA (TTM)
1.56BCNY232.30M · vs all stocks (USD)
Net Income (TTM)
373.94MCNY55.61M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
4.30%Operating Cash Flow (TTM)
444.32MCNY66.08M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
335.90MCNY49.95M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1800CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
1.15%vs all stocks
5-Year Average Dividend Yield
2.66%vs all stocks
Payout Ratio
109.49%Minority Interest (Equity)
-575.45MCNYFY2025 · Dec 31, 2025Revenue
11.88BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.40BCNYFY2025 · Dec 31, 2025Gross Profit
7.48BCNYFY2025 · Dec 31, 2025Operating Income
1.48BCNY219.42M · vs all stocks (USD)
Pre-tax Income
533.96MCNYFY2025 · Dec 31, 2025Income Tax Expense
341.66MCNYFY2025 · Dec 31, 2025Net Income
192.30MCNYFY2025 · Dec 31, 2025EBIT
652.66MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.96BCNYFY2025 · Dec 31, 2025Research & Development
240.10MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
5.00BCNYFY2025 · Dec 31, 2025Other Operating Expenses
176.01MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.84MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
118.70MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3416CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3416CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.06BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.06BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
192.30MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
168.49MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-380.23MCNYFY2025 · Dec 31, 2025Free Cash Flow
-503.44MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.21BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
192.30MCNYFY2025 · Dec 31, 2025Other Non-cash Items
121.17MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-684.54MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-9.15MCNYFY2025 · Dec 31, 2025Capital Expenditures
-123.21MCNYFY2025 · Dec 31, 2025Purchase of Investments
-30.00MCNYFY2025 · Dec 31, 2025Sale of Investments
106.28MCNYFY2025 · Dec 31, 2025Other Investing Activity
4.90MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-42.03MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.85BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.96BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-530.71MCNYFY2025 · Dec 31, 2025Other Financing Charges
-68.53MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-712.62MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.05BSharesUpdated Aug 21, 2026Float Shares
394.88MSharesUpdated Aug 21, 2026% Held by Insiders
62.56%vs all stocks
% Held by Institutions
4.41%vs all stocks
Total Cash (MRQ)
1.87BCNY277.92M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.77CNYUpdated Aug 21, 2026Total Debt (MRQ)
4.55BCNY676.63M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.4729xCurrent Ratio (MRQ)
1.22xBook Value per Share (MRQ)
9.69CNYUpdated Aug 21, 2026Total Assets
19.24BCNY2.86B · vs all stocks (USD)
Total Current Assets
7.89BCNYFY2025 · Dec 31, 2025Total Liabilities
9.81BCNYFY2025 · Dec 31, 2025Total Non-current Assets
11.35BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.64BCNYFY2025 · Dec 31, 2025Total Current Liabilities
7.17BCNYFY2025 · Dec 31, 2025Cash
1.20BCNYFY2025 · Dec 31, 2025Cash Equivalents
20.86MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.22BCNYFY2025 · Dec 31, 2025Other Short-term Investments
33.08MCNYFY2025 · Dec 31, 2025Accounts Receivable
674.28MCNYFY2025 · Dec 31, 2025Inventory
4.50BCNYFY2025 · Dec 31, 2025Accounts Payable
2.54BCNYFY2025 · Dec 31, 2025Short-term Debt
1.45BCNYFY2025 · Dec 31, 2025Other Current Liabilities
33.12MCNYFY2025 · Dec 31, 2025Long-term Debt
2.15BCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.05BCNYFY2025 · Dec 31, 2025Retained Earnings
6.70BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
9.44BCNY1.40B · vs all stocks (USD)
52-Week Low
14.01CNYUpdated Aug 21, 202652-Week High
20.58CNYUpdated Aug 21, 202652-Week Change
-17.71%vs all stocks
Beta
0.2960xvs all stocks
50-Day MA
15.53CNYUpdated Aug 21, 2026200-Day MA
16.29CNYUpdated Aug 21, 2026Avg 10-Day Volume
8.35MSharesUpdated Aug 21, 2026Avg 30-Day Volume
7.84MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.3600CNYUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.63Profit Margin: 0.03
Financial Health
Altman Z-Score 2.3: grey zoneSignificant
Altman Z-Score: 2.30
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $2.54B, above the global median of $1.15BNotable
Market cap (USD): 2,538,994,693.883Global Median: 1,146,734,693.424
Revenue is $1.74B, above the global median of $520.53MNotable
Revenue (USD): 1,735,308,896.317Global Median: 520,528,949.311
Levered free cash flow is $49.95M, above the global median of $16.24MNotable
Levered free cash flow (USD): 49,951,841.279Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
GN Store Nord A/S
Tier 1ProductionApproval-Gated PipelineRuleFlow
Immunome Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
TransMedics Group Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Guangzhou Innogen Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
China Resources Double Crane Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sellas Life Sciences Group Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
ApicHope Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Curaleaf Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Regencell Bioscience Holdings Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tonghua Dongbao Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule